These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 362511)

  • 1. The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (prostacyclin) on platelet function.
    Nordøy A; Svensson B; Haycraft D; Hoak JC; Wiebe D
    Scand J Haematol; 1978 Sep; 21(3):177-87. PubMed ID: 362511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML; Jaffe EA
    Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
    Norris LA; Devitt M; Bonnar J
    Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of aspirin on human endothelial cells.
    Nordoy A; Svensson B; Schroeder C; Hoak JC
    Thromb Haemost; 1978 Aug; 40(1):103-10. PubMed ID: 364762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet factor 3 availability by prostacyclin.
    Hársfalvi J; Muszbek L; Stadler I; Fésüs L
    Prostaglandins; 1980 Nov; 20(5):935-45. PubMed ID: 7008092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
    Eldor A; Vlodavsky I; Fuks Z; Muller TH; Eisert WG
    Thromb Haemost; 1986 Dec; 56(3):333-9. PubMed ID: 3551181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G; Silver MJ; de Gaetano G
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
    Briel RC; Lippert TH
    Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives.
    Pan IQ; Hall ER; Wu KK
    Br J Haematol; 1984 Oct; 58(2):317-23. PubMed ID: 6089860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM; Forscher CA; Sussman II; Mueller HS
    Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin (ASA) renders human platelets more vulnerable to inhibition of aggregation by prostacyclin (PGI2).
    Philp RB; Paul ML
    Prostaglandins Leukot Med; 1983 Jun; 11(2):131-42. PubMed ID: 6348804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.